BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 3311623)

  • 1. Treatment of increased menstrual blood loss in IUD users.
    Toppozada M
    Contraception; 1987 Jul; 36(1):145-57. PubMed ID: 3311623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Management of abnormal bleeding in an intrauterine device user].
    Desmons F; Adam-steen C
    Cah Sexol Clin; 1985; 11(63):185-7. PubMed ID: 12281357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Can intrauterine device removals for bleeding or pain be predicted at a one-month follow-up visit? A multivariate analysis.
    Stanback J; Grimes D
    Contraception; 1998 Dec; 58(6):357-60. PubMed ID: 10095972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative studies on menstrual blood loss in IUD users.
    Andrade AT; Pizarro Orchard E
    Contraception; 1987 Jul; 36(1):129-44. PubMed ID: 3311622
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Menstrual bleeding with copper-covered intrauterine contraceptive devices.
    Malmqvist R; Petersohn L; Bengtsson LP
    Contraception; 1974 Jun; 9(6):627-33. PubMed ID: 4448089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An evaluation of the levonorgestrel-releasing IUD: its advantages and disadvantages when compared to the copper-releasing IUDs.
    Chi IC
    Contraception; 1991 Dec; 44(6):573-88. PubMed ID: 1773615
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced menstrual blood loss by release of an antifibrinolytic agent from intrauterine contraceptive devices.
    Tauber PF; Kloppel A; Goodpasture JC; Burns J; Ludwig H; Zaneveld LJ
    Am J Obstet Gynecol; 1981 Jun; 140(3):322-8. PubMed ID: 7246636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of bleeding irregularities in women with copper-containing IUDs: a systematic review.
    Godfrey EM; Folger SG; Jeng G; Jamieson DJ; Curtis KM
    Contraception; 2013 May; 87(5):549-66. PubMed ID: 23199413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Menstrual flow duration and spotting following Multiload Copper 250 intra-uterine device insertion.
    Goh TH; Ang ES; Yip YC
    J Obstet Gynaecol (Lahore); 1983 Oct; 4(2):127-8. PubMed ID: 12279948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of adenomyosis-associated menorrhagia with a levonorgestrel-releasing intrauterine device.
    Fedele L; Bianchi S; Raffaelli R; Portuese A; Dorta M
    Fertil Steril; 1997 Sep; 68(3):426-9. PubMed ID: 9314908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IUD-induced uterine bleeding.
    El-badrawi HH; Hafez ES
    Contracept Deliv Syst; 1980 Oct; 1(4):303-18. PubMed ID: 12262133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intrauterine devices: an effective alternative to oral hormonal contraception.
    Prescrire Int; 2009 Jun; 18(101):125-30. PubMed ID: 19637436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Menstrual characteristics and ultrasonographic uterine cavity measurements predict bleeding and pain in nulligravid women using intrauterine contraception.
    Kaislasuo J; Heikinheimo O; Lähteenmäki P; Suhonen S
    Hum Reprod; 2015 Jul; 30(7):1580-8. PubMed ID: 25990577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acceptability of an experimental intracervical device: results of a study controlling for selection bias.
    Shain RN; Ratsula K; Toivonen J; Lähteenmäki P; Luukkainen T; Holden AE; Rosenthal M
    Contraception; 1989 Jan; 39(1):73-84. PubMed ID: 2491982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influences of copper and design of intrauterine devices on endometrial bleeding in monkeys.
    Shaw ST; Forino RV; Poon CH; Moyer DL
    Contraception; 1976 Jul; 14(1):9-15. PubMed ID: 824096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Steroid intra-uterine contraception: progesterone-releasing devices. II. Insertion, clinical problems and contraceptive dependability].
    Custo GM; Cosmi EV
    Patol Clin Ostet Ginecol; 1984; 12(4):331-43. PubMed ID: 12340352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endometrial morphological changes in IUD users: a review.
    Sheppard BL
    Contraception; 1987 Jul; 36(1):1-10. PubMed ID: 3117492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A risk-benefit assessment of the levonorgestrel-releasing intrauterine system.
    Sturridge F; Guillebaud J
    Drug Saf; 1996 Dec; 15(6):430-40. PubMed ID: 8968696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Postpartum IUDS: keys for success.
    O'Hanley K; Huber DH
    Contraception; 1992 Apr; 45(4):351-61. PubMed ID: 1516367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Editorial: IUDs and heavy periods.
    Br Med J; 1976 Feb; 1(6005):304. PubMed ID: 1247833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.